Rocket Lab (RKLB) Stock Surges Past $120 as Wall Street Analysts Raise Price Targets

Key Takeaways

• Rocket Lab shares climbed 11.3%, reaching an intraday peak of $123.94 following Needham’s price target increase from $95 to $120 with a Buy rating maintained.
• Cantor Fitzgerald elevated its target to $96 from $85, highlighting improved launch performance and expanding space services portfolio.
• First-quarter revenue reached $200.35 million, marking a 63.4% year-over-year increase and surpassing analyst estimates of $189.65 million.
• Earnings per share met projections at -$0.07, with management increasing second-quarter guidance.
• Analysts maintain a “Moderate Buy” consensus with an average target price of $91.79.

Shares of Rocket Lab USA (RKLB) jumped 11.3% during Monday’s trading session after Needham & Company increased its price objective from $95 to $120 while reaffirming its Buy recommendation on the space technology company.

Rocket Lab USA, Inc., RKLB

The aerospace stock touched an intraday peak of $123.94 before closing near $117.35. Trading volume surged to approximately 53 million shares, exceeding twice the typical daily average of 23.3 million.

The rally followed impressive first-quarter financial results. Rocket Lab delivered revenue of $200.35 million in Q1, surpassing Wall Street’s consensus estimate of $189.65 million and marking a robust 63.4% year-over-year expansion.

The company reported earnings per share of -$0.07, matching analyst projections. This represents a significant improvement from the -$0.12 per share loss recorded in the same period last year.

Management also upgraded its second-quarter outlook, further bolstering investor confidence in the stock.

Wall Street Backs the Rally

Cantor Fitzgerald added to the optimistic sentiment, lifting its price objective to $96 from $85 while maintaining an Overweight stance. The firm highlighted Rocket Lab’s operational excellence in launches and its expanding service offerings, which include the Electron launch vehicle, the Haste hypersonic testing platform, and the forthcoming Neutron rocket program.

Stifel Nicolaus maintained its Buy recommendation and increased its target from $90 to $105. Bank of America has established a $120 target. Citigroup confirmed its Outperform rating late last week.

Despite these optimistic projections from multiple firms, the consensus average target of $91.79 remains significantly below current trading levels. This discrepancy illustrates the stock’s rapid appreciation.

Among Wall Street analysts tracking RKLB, two rate it Strong Buy, ten recommend Buy, four suggest Hold, and one advises Sell.

First Quarter Performance Breakdown

Rocket Lab recorded a negative return on equity of 11.72% and a net margin of -26.87%, typical metrics for a high-growth aerospace company.

The first-quarter outperformance stemmed from robust results across both launch operations and spacecraft systems divisions. Cantor highlighted the company’s strategic dual launch facility locations in New Zealand and the United States as a competitive differentiator.

Rocket Lab commands a market capitalization of approximately $66.82 billion, maintains a minimal debt-to-equity ratio of 0.02, and shows a current ratio of 4.47, indicating strong short-term financial flexibility.

The stock’s 50-day moving average sits at $72.88, while the 200-day average stands at $68.50, both significantly beneath current price levels.

Insider activity has trended toward selling. Over the past three months, company insiders disposed of approximately 233,449 shares valued at more than $16.4 million. SVP Arjun Kampani sold shares in early March at an average price of $69.59, while Director Merline Saintil sold at $75.04. Company insiders retain roughly 8.4% ownership, with institutional investors controlling 71.78%.

Wall Street projects full-year EPS of -$0.22 for the current fiscal period.

The post Rocket Lab (RKLB) Stock Surges Past $120 as Wall Street Analysts Raise Price Targets appeared first on Blockonomi.